According to filings with the U.S. Securities and Exchange Commission, Reservoir Neuroscience is raising up to $8 Million in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Reservoir Neuroscience
Reservoir Neuroscience is a biotechnology company developing the worlds first therapeutics to heal the blood-brain barrier, with the goal of transforming the treatment of brain disease. Its work centers on understanding and repairing broken blood vessels in the brain, targeting the vascular damage that underlies many neurological and aging-related conditions. By focusing on the health and integrity of the blood-brain barrier, Reservoir Neuroscience aims to address a critical and previously untargeted driver of neurodegeneration. Positioned as an innovation-driven neuroscience lab, the company emphasizes cutting-edge research at the intersection of vascular biology and brain health. Through this specialized approach, Reservoir Neuroscience seeks to establish itself as a pioneer in bloodbrain barrier therapeutics and a leader in next-generation treatments for brain disease.

To learn more, visit https://www.reservoirneuro.com/
LinkedIn: https://www.linkedin.com/company/reservoirneuro/

Contact:
Aaron Friedman, Chief Executive Officer

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.